Jiangsu Hengrui Medicine
600276.SS
#426
Rank
NZ$92.48 B
Marketcap
NZ$13.89
Share price
6.88%
Change (1 day)
18.87%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

EPS for Jiangsu Hengrui Medicine (600276.SS)

EPS in 2025 (TTM): NZ$0.21

According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is NZ$0.22. In 2024 the company made an earnings per share (EPS) of NZ$0.24 an increase over its 2023 EPS that were of NZ$0.17.

EPS history for Jiangsu Hengrui Medicine from 2000 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$0.21-12.39%
2024NZ$0.2442.43%
2023NZ$0.178.77%
2022NZ$0.15-20.62%
2021NZ$0.19-26.59%
2020NZ$0.2627.24%
2019NZ$0.2128.41%
2018NZ$0.1620.04%
2017NZ$0.1331.21%
2016NZ$0.1011.46%
2015NZ$0.0920736.27%
2014NZ$0.0675719.77%
2013NZ$0.0564118.05%
2012NZ$0.0477923.9%
2011NZ$0.0385726.9%
2010NZ$0.0303912.37%
2009NZ$0.0270556.6%
2008NZ$0.017279.18%
2007NZ$0.01582114.48%
2006NZ$0.00737664.83%
2005NZ$0.00447535.55%
2004NZ$0.00330229.73%
2003NZ$0.00254519.86%
2002NZ$0.002123-2.71%
2001NZ$0.0021821.02%
2000NZ$0.002160